Implementing Risk-Based Monitoring in Rare Disease Trials
Implementing Risk-Based Monitoring in Rare Disease Trials Designing Risk-Based Monitoring Strategies for Rare Disease Clinical Trials Why Risk-Based Monitoring is Essential in Rare Disease Studies Rare disease trials face unique challenges that make traditional, intensive on-site monitoring inefficient and often unsustainable. Small patient populations, dispersed across numerous global sites, mean fewer patients per site and…
Read More “Implementing Risk-Based Monitoring in Rare Disease Trials” »